Danka Radosavljevic
Vermögen: 1 Mio $ am 31.07.2026
Vermögen: 1 Mio $ am 31.07.2026
Danka Radosavljevic is currently Chief Operating Officer at Eton Pharmaceuticals, Inc. Formerly, Mr. Radosavljevic worked as a Project Manager at Akorn, Inc. and as a Quality Control & Analytical Development Scientist at Morton Grove Pharmaceuticals, Inc. Mr. Radosavljevic completed undergraduate studies at the University of Illinois.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.07.2026 | 22.473 ( 0,08 % ) | 1 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Geschäftsführer | - |
| Unternehmen | Position | Ende |
|---|---|---|
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Corporate Officer/Principal | - |
| AKORN, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen